Royalty Pharma Sub-Manager, LLC historic quarter change: Foreign Funds, Sold out
In funds and trusts that are not on this site's ETF list (sponsor series, commodity pools, money market) (depositary receipts and foreign shares traded over the counter), over 2 quarters from 2025-12-31 to 2026-06-30, Royalty Pharma Sub-Manager, LLC opened 0 positions, added to 0, reduced 0 and sold out of 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 2081668), 2 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-21); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-08-21). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2025-12-31.
No position of this class changed this way in the filings compared.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Marest Capital, LLC | United States | $0.173B | 29 |
| Dynamic Wealth Strategies, LLC | United States | $0.173B | 288 |
| Kurv Investment Management LLC | United States | $0.173B | 62 |
| Capital Today Evergreen Fund, L.P. | Cayman Islands | $0.173B | 3 |
| PETERSON WEALTH MANAGEMENT | United States | $0.172B | 166 |
| Godshalk Welsh Capital Management, Inc. | United States | $0.172B | 129 |
| Forbes Financial Planning, Inc. | United States | $0.173B | 38 |
| Innovative Asset Advisors Group, LLC | United States | $0.173B | 1,040 |
| Saxony Capital Management, LLC | United States | $0.172B | 161 |
| Tiptree Advisors, LLC | United States | $0.172B | 22 |